Sung Yong Oh

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Jung Hun Kang, Soon Il Lee, Do Hyoung Lim et al. · Journal of Clinical Oncology · 2012 · 672 citations

Medicine, Oncology, Chemotherapy +5

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 614 citations · Full text

Medicine, Oncology, Cancer Immunology +12

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

Byeong-Ho Park, Tae-Ho Hwang, Ta‐Chiang Liu et al. · The Lancet Oncology · 2008 · 522 citations

Medicine, Oncology, Pharmacotherapy +15

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

Hyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh et al. · Biomarkers · 2012 · 409 citations

Medicine, Hematology, Oncology +15

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17